NASONEX 24HR ALLERGY FDA approval date
The FDA approved NASONEX 24HR ALLERGY on 17 Mar 2022.
- FDA approval date
- 17 Mar 2022
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as MOMETASONE FUROATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2022-03-17Day | NASONEX 24HR ALLERGY | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA215712", "applicant_as_listed_by_fda": "PERRIGO PHARMA INTL", "brand_names": ["NASONEX 24HR ALLERGY"], "active_ingredients": ["MOMETASONE FUROATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220317", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |